165 related articles for article (PubMed ID: 8812204)
1. Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand white rabbits.
Blazak WF; Brown GL; Gray TJ; Treinen KA; Denny KH
Fundam Appl Toxicol; 1996 Sep; 33(1):11-5. PubMed ID: 8812204
[TBL] [Abstract][Full Text] [Related]
2. Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats.
Treinen KA; Gray TJ; Blazak WF
Teratology; 1995 Aug; 52(2):109-15. PubMed ID: 8588182
[TBL] [Abstract][Full Text] [Related]
3. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit.
Grant D; Blazak WF; Brown GL
Acta Radiol; 1997 Jul; 38(4 Pt 2):759-69. PubMed ID: 9245972
[TBL] [Abstract][Full Text] [Related]
4. General toxicology of MnDPDP.
Larsen LE; Grant D
Acta Radiol; 1997 Jul; 38(4 Pt 2):770-9. PubMed ID: 9245973
[TBL] [Abstract][Full Text] [Related]
5. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the developmental toxicity of methacrylonitrile in Sprague-Dawley rats and New Zealand white rabbits.
George JD; Price CJ; Marr MC; Myers CB; Schwetz BA; Heindel JJ; Hunter ES
Fundam Appl Toxicol; 1996 Dec; 34(2):249-59. PubMed ID: 8954754
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
[TBL] [Abstract][Full Text] [Related]
8. MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion.
Thorstensen O; Isberg B; Jorulf H; Westman L; Svahn U; Venizelos N
Acta Radiol; 1997 Jul; 38(4 Pt 2):717-23. PubMed ID: 9245967
[TBL] [Abstract][Full Text] [Related]
9. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2.
Ni Y; Petré C; Bosmans H; Miao Y; Grant D; Baert AL; Marchal G
Acta Radiol; 1997 Jul; 38(4 Pt 2):700-7. PubMed ID: 9245965
[TBL] [Abstract][Full Text] [Related]
10. NMR relaxation studies with MnDPDP.
Southon TE; Grant D; Bjørnerud A; Moen OM; Spilling B; Martinsen I; Refsum H
Acta Radiol; 1997 Jul; 38(4 Pt 2):708-16. PubMed ID: 9245966
[TBL] [Abstract][Full Text] [Related]
11. Developmental toxicity evaluation of sodium thioglycolate administered topically to Sprague-Dawley (CD) rats and New Zealand White rabbits.
Tyl RW; Price CJ; Marr MC; Myers CB; van Birgelen AP; Jahnke GD
Birth Defects Res B Dev Reprod Toxicol; 2003 Apr; 68(2):144-61. PubMed ID: 12866706
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
Federle MP; Chezmar JL; Rubin DL; Weinreb JC; Freeny PC; Semelka RC; Brown JJ; Borello JA; Lee JK; Mattrey R; Dachman AH; Saini S; Harmon B; Fenstermacher M; Pelsang RE; Harms SE; Mitchell DG; Halford HH; Anderson MW; Johnson CD; Francis IR; Bova JG; Kenney PJ; Klippenstein DL; Foster GS; Turner DA
J Magn Reson Imaging; 2000 Jul; 12(1):186-97. PubMed ID: 10931579
[TBL] [Abstract][Full Text] [Related]
13. Developmental toxicity of cyclohexanediaminetetraacetic acid (CDTA) in mice.
Sánchez DJ; Colomina MT; Domingo JL; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):329-40. PubMed ID: 8008982
[TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary MR imaging: first human experience with MnDPDP.
Lim KO; Stark DD; Leese PT; Pfefferbaum A; Rocklage SM; Quay SC
Radiology; 1991 Jan; 178(1):79-82. PubMed ID: 1898539
[TBL] [Abstract][Full Text] [Related]
15. Axon tracing in the adult rat optic nerve and tract after intravitreal injection of MnDPDP using a semiautomatic segmentation technique.
Olsen Ø; Thuen M; Berry M; Kovalev V; Petrou M; Goa PE; Sandvig A; Haraldseth O; Brekken C
J Magn Reson Imaging; 2008 Jan; 27(1):34-42. PubMed ID: 18157895
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterisation of mangafodipir trisodium.
Tirkkonen B; Aukrust A; Couture E; Grace D; Haile Y; Holm KM; Hope H; Larsen A; Lunde HS; Sjøgren CE
Acta Radiol; 1997 Jul; 38(4 Pt 2):780-9. PubMed ID: 9245974
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Federle M; Chezmar J; Rubin DL; Weinreb J; Freeny P; Schmiedl UP; Brown JJ; Borrello JA; Lee JK; Semelka RC; Mattrey R; Dachman AH; Saini S; Harms SE; Mitchell DG; Anderson MW; Halford HH; Bennett WF; Young SW; Rifkin M; Gay SB; Ballerini R; Sherwin PF; Robison RO
J Magn Reson Imaging; 2000 Nov; 12(5):689-701. PubMed ID: 11050638
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.
Elizondo G; Fretz CJ; Stark DD; Rocklage SM; Quay SC; Worah D; Tsang YM; Chen MC; Ferrucci JT
Radiology; 1991 Jan; 178(1):73-8. PubMed ID: 1898538
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study.
Wang C; Ahlström H; Ekholm S; Fagertun H; Hellström M; Hemmingsson A; Holtås S; Isberg B; Jonnson E; Lönnemark-Magnusson M; McGill S; Wallengren NO; Westman L
Acta Radiol; 1997 Jul; 38(4 Pt 2):643-9. PubMed ID: 9245958
[TBL] [Abstract][Full Text] [Related]
20. Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Eser G; Karabacakoglu A; Karakose S; Eser C; Kayacetin E
World J Gastroenterol; 2006 Mar; 12(10):1603-6. PubMed ID: 16570354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]